QT
AVIR icon

Quantbot Technologies’s Atea Pharmaceuticals AVIR Stock Holding History

Quantbot Technologies’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,522
Closed -$34.4K – 1427
2024
Q1 		$34.4K Buy
8,522
+1,300
+18% +$5.09K ﹤0.01% 1371
2023
Q4 		$22K Hold
7,222
– – ﹤0.01% 1420
2023
Q3 		$21.7K Sell
7,222
-6,200
-46% -$21.1K ﹤0.01% 1341
2023
Q2 		$50.2K Buy
13,422
+1,061
+9% +$3.97K ﹤0.01% 1323
2023
Q1 		$41.4K Buy
12,361
+8,560
+225% +$34.7K ﹤0.01% 1282
2022
Q4 		$18.3K Buy
3,801
+3,556
+1,451% +$18K ﹤0.01% 1456
2022
Q3 		$1K Sell
245
-1,463
-86% -$11.2K ﹤0.01% 1526
2022
Q2 		$12K Buy
+1,708
New +$11.7K ﹤0.01% 1512
2022
Q1 		– Sell
-3,313
Closed -$29K – 1630
2021
Q4 		$29K Buy
3,313
+2,513
+314% +$39.2K ﹤0.01% 1161
2021
Q3 		$28K Buy
+800
New +$22.2K ﹤0.01% 1210

Other funds holding AVIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Quantbot Technologies's AVIR Position: Q2 2024 in Review

Quantbot Technologies sold out of Atea Pharmaceuticals (AVIR) in Q2 2024, closing a stake of 8,522 shares — an estimated $34.4K sold.

Quantbot Technologies first reported a position in AVIR in Q3 2021 and held it in 10 quarters. The position peaked at $50.2K in Q2 2023. 105 funds tracked by Wall St. Rank hold AVIR as of Q2 2024.

  • Quantbot Technologies reported no remaining Atea Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 8,522 Atea Pharmaceuticals shares in Q2 2024, an estimated $34.4K.
  • Quantbot Technologies first reported a position in Atea Pharmaceuticals in Q3 2021 and held it in 10 quarters.
  • Quantbot Technologies's Atea Pharmaceuticals position peaked at $50.2K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.